PARP inhibitors
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
PARP inhibitors
May 8, 2024, 23:17 |
Insight
Giampaolo Bianchini: Join us at the next ESMO Virtual Plenary session!
Elisa Agostinetto, Research Physician at Institute of Jules Bordet in Brussels, shared a post by Giampaolo…
May 6, 2024, 09:49 |
Insight
Wafik S. El-Deiry: RI Cancer Action Day
Wafik S. El-Deiry shared a post on LinkedIn: “Stopped by the Rhode Island Statehouse this afternoon…
Apr 30, 2024, 19:43 |
Insight
Erman Akkus: Our new study Prostate Cancer and PARPi
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Our…
Apr 17, 2024, 19:06 |
Drugs
New research from Dr. Jung-Min Lee has identified a potential drug to treat ovarian cancers - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Milestones Monday: Ovarian cancer is the most lethal…
Mar 23, 2024, 23:31 |
Blog
Antonio Marra: Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology
Antonio Marra, Medical Oncologist at the European Institute of Oncology, on LinkedIn: “Excited to see…
Mar 22, 2024, 00:59 |
Insight
Sharlene Gill: Happy to share the inaugural issue of Canadian Oncology Today
Sharlene Gill shared on LinkedIn: "Vol 1, Issue 1: Happy to share the inaugural issue…
Feb 29, 2024, 14:42 |
Blog
Rasha Aboelhassan: Presenting updated NCCN Guidelines for epithelial ovarian cancer to a group of professionals and young oncologists was a rewarding experience
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: “Presenting updated NCCN Guidelines for…
Jan 18, 2024, 15:12 |
Blog
Maria Natalia Gandur Quiroga: Immuno-Oncology Advances in Genitourinary Cancers
Maria Natalia Gandur Quiroga shared a post on LinkedIn: "Immuno-Oncology Advances in Genitourinary Cancers: Introduction:…
Dec 20, 2023, 11:19 |
Blog
Yüksel Ürün: PARP inhibitors in treating prostate cancer
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: “Thrilled to share our latest…
Sep 3, 2023, 17:26 |
Opinion
Paz Polak: In a correspondence letter we wrote for the NEJM, we suggested that testing for POLE, and even better, checking for POLE-associated mutational signatures.
Paz Polak, VP of Computational Biology, C2i Genomics, recently posted on LinkedIn: "In a correspondence…
1
2
All:
11
Posts:
1 - 10
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
Facebook
RSS Feed
Twitter
Linkedin
Youtube